Literature DB >> 3129661

Activation of human immunodeficiency virus type 1 by DNA damage in human cells.

K Valerie1, A Delers, C Bruck, C Thiriart, H Rosenberg, C Debouck, M Rosenberg.   

Abstract

Recent studies indicate that human immunodeficiency virus type 1 (HIV) gene expression can be dramatically enhanced by certain heterologous viral and chemical agents, implicating these as potential reactivating agents of latent virus infection. A common denominator shared by these agents is their ability to cause stress responses in cells. In an effort to determine whether stress responses affect HIV gene expression, we examined the effects of ultraviolet light (UV) and mitomycin C, on HIV gene expression as well as on viral growth and development. We demonstrate that these agents enhance HIV gene expression up to 150-fold. These levels are similar to those obtained by the tat gene product, the HIV trans-activating factor responsible for enhancing viral gene expression. The increase in gene expression after UV irradiation appears to require transcription but not de novo protein synthesis, and correlates with an accumulation of stable mRNA. Most importantly, UV irradiation of human T-cells prior to viral infection significantly shortens the viral growth cycle. Apparently, UV-induced cellular stress is highly conducive for viral replication and growth. We further demonstrate that even direct sunlight can activate HIV gene expression. These results demonstrate that DNA damaging agents, and perhaps other agents which elicit SOS-like stress responses in mammalian cells, can activate HIV expression thereby enhancing viral replication and development.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129661     DOI: 10.1038/333078a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  51 in total

1.  DNA damage activates transcription and transposition of yeast Ty retrotransposons.

Authors:  V A Bradshaw; K McEntee
Journal:  Mol Gen Genet       Date:  1989-09

2.  Rapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency.

Authors:  C M Drysdale; G N Pavlakis
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Potential of Radiation-Induced Cellular Stress for Reactivation of Latent HIV-1 and Killing of Infected Cells.

Authors:  Sergey Iordanskiy; Fatah Kashanchi
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02       Impact factor: 2.205

4.  Repeated use of GAL1 for gene disruption in Candida albicans.

Authors:  J A Gorman; W Chan; J W Gorman
Journal:  Genetics       Date:  1991-09       Impact factor: 4.562

Review 5.  Radiation-induced activation of transcription factors in mammalian cells.

Authors:  M Krämer; B Stein; S Mai; E Kunz; H König; H Loferer; H H Grunicke; H Ponta; P Herrlich; H J Rahmsdorf
Journal:  Radiat Environ Biophys       Date:  1990       Impact factor: 1.925

6.  DNA damage by the glycation products of glyceraldehyde 3-phosphate and lysine.

Authors:  E A Mullokandov; W A Franklin; M Brownlee
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

7.  DNA damage induction of ribonucleotide reductase.

Authors:  S J Elledge; R W Davis
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

8.  Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV.

Authors:  K Bender; M Göttlicher; S Whiteside; H J Rahmsdorf; P Herrlich
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.

Authors:  Ozlem Equils; Alan Shapiro; Zeynep Madak; Chunren Liu; Daning Lu
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.

Authors:  M O Westendorp; M Li-Weber; R W Frank; P H Krammer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.